Global Embolotherapy Market
Embolotherapy is defined as an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter helps to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect. Embolotherapy is also used to stop blood flow towards & around a tumor during surgery.
Market Drivers
The embolotherapy market has experienced steady growth from past few years, due to the increase in target patient population base, which has raised the number of target surgeries performed. CVD is a major target disease; its importance & high prevalence have made it a focus for research on successful & effective therapies. For instance, as per the information provided by Elsevier, 2018, around 200 million people are suffering from peripheral vascular diseases across the globe.
The high success rate & less post-operative complications rate related with embolotherapy procedures coupled with the increase in incidences of liver cancer and hepatocellular cancer will further propel the demand for embolotherapy devices in the near future. Liver cancer is the 5th most common cancer in men and the 9th most-common in women. For instance, as per the information provided by the World Cancer Research Fund, around 840,000 new cases diagnosed in 2018, across the globe. This is expected to drive the growth of global embolotherapy market growth during the forecast period.
Market Restraints
The availability of effective conventional first-level therapies for the treatment of uterine fibroids, hemorrhagic stroke, liver cancer, and other hemorrhagic conditions is a main restraint which may hamper the growth of global embolotherapy market over the forecast period. For example, therapies like surgery, chemotherapy, and radiation therapy are preferred options in cancer treatment, owing to the high awareness among individuals about traditional therapies cancer treatments as well as low adoption of advanced treatments in developing countries.
Market Segmentation
The Global Embolotherapy Market is segmented into product such as Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices (Guidewires, and Microcatheters). Further, market is segmented into application such as Oncology (Liver Cancer, Kidney cancer, Lung cancer, Breast Cancer, and Other Cancers), Peripheral Vascular Diseases, Urology and Nephrology, Neurology, and GIT Disorders. On the basis of procedure, the market is segmented into Transcatheter Arterial Embolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, and Transarterial Chemoembolization. Also, the market is segmented into end user such as Hospitals and Clinics, Ambulatory Surgical Centers, and Others.
Regional Analysis
The Global Embolotherapy Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America is anticipated to dominate the global embolotherapy market during this forecast period. Due to the increase in investment in healthcare industry in this region, will likely create lucrative opportunities for growth in North America region. Also, the Asia Pacific market is anticipated to grow at the highest CAGR over the forecast period. Due to the improving healthcare infrastructure in the APAC region. Also, the large patient population for large diseases, and expanding presence of key market players are expected to accelerate the global embolotherapy market growth in the region.
Key Players
The major players in the embolotherapy market are Medtronic, Johnson & Johnson, Stryker Corporation, Terumo Medical Systems, Boston Medical Corporation, Kaneka Corporation, Cook Medical, BTG PLC, Abbott Laboratories, Acandis GmbH, etc.
Market Taxonomy
By Product
By Application
By Procedure
By End User
By Region
Key Questions Addressed by the Report
Global Embolotherapy Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Embolotherapy Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Embolotherapy Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Embolotherapy Market Share Analysis, By Product
5.3 Global Embolotherapy Market Size and Forecast, By Product
5.3.1 Embolization Coil
5.3.2 Embolic Agents
5.3.3 Detachable Balloons
5.3.4 Embolic Plug Systems
5.3.5 Support Devices
5.3.5.1. Guidewires
5.3.5.2. Microcatheters
6 Global Embolotherapy Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Embolotherapy Market Share Analysis, By Application
6.3 Global Embolotherapy Market Size and Forecast, By Application
6.3.1 Oncology
6.3.1.1. Liver Cancer
6.3.1.2. Kidney Cancer
6.3.1.3. Lung cancer
6.3.1.4. Breast Cancer
6.3.1.5. Other Cancers
6.3.2 Peripheral Vascular Diseases
6.3.3. Urology and Nephrology
6.3.4. Neurology
6.3.5. GIT Disorders
7 Global Embolotherapy Market, By Procedure
7.1 Y-o-Y Growth Comparison, By Procedure
7.2 Global Embolotherapy Market Share Analysis, By Procedure
7.3 Global Embolotherapy Market Size and Forecast, By Procedure
7.3.1 Transcatheter Arterial Embolization
7.3.2 Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
7.3.3 Transarterial Chemoembolization
8 Global Embolotherapy Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Embolotherapy Market Share Analysis, By End User
8.3 Global Embolotherapy Market Size and Forecast, By End User
8.3.1 Hospitals and Clinics
8.3.2 Ambulatory Surgical Centers
8.3.3 Others
9Global Embolotherapy Market, By Region
9.1 Global Embolotherapy Market Share Analysis, By Region
9.2 Global Embolotherapy Market Share Analysis, By Region
9.3 Global Embolotherapy Market Size and Forecast, By Region
10 North America Embolotherapy Analysis and Forecast (2020 – 2030)
10.1 Introduction
10.2 North America Embolotherapy Product Market Share Analysis, By Product
10.3 North America Embolotherapy Product Market Size and Forecast, By Application
10.4 North America Embolotherapy Product Market Size and Forecast, By Procedure
10.5 North America Embolotherapy Product Market Size and Forecast, By End User
10.6 North America Embolotherapy Product Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11Europe Embolotherapy Maket Analysis and Forecast (2020 – 2030)
11.1 Introduction
11.2 Europe Embolotherapy Product Market Share Analysis, By Product
11.3 Europe Embolotherapy Product Market Size and Forecast, By Application
11.4 Europe Embolotherapy Product Market Size and Forecast, By Procedure
11.5 Europe Embolotherapy Product Market Size and Forecast, By End User
11.6 Europe Embolotherapy Product Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.64. Rest of Europe
12Asia Pacific Embolotherapy Market Analysis and Forecast (2020 – 2030)
12.1 Introduction
12.2 Asia Pacific Embolotherapy Product Market Share Analysis, By Product
12.3 Asia Pacific Embolotherapy Product Market Size and Forecast, By Application
12.4 Asia Pacific Embolotherapy Product Market Size and Forecast, By Procedure
12.5 Asia Pacific Embolotherapy Product Market Size and Forecast, By End User
12.6 Asia Pacific Embolotherapy Product Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13Latin America Embolotherapy Market Analysis and Forecast (2020 – 2030)
13.1 Introduction
13.2 Latin America Embolotherapy Product Market Share Analysis, By Product
13.3 Latin America Embolotherapy Product Market Size and Forecast, By Application
13.4 Latin America Embolotherapy Product Market Size and Forecast, By Procedure
13.5 Latin America Embolotherapy Product Market Size and Forecast, By End User
13.6 Latin America Embolotherapy Product Market Size and Forecast, By Country
14Middle East Embolotherapy Market Analysis and Forecast (2020 – 2030)
14.1 Introduction
14.2 Middle East Embolotherapy Product Market Share Analysis, By Product
14.3 Middle East Embolotherapy Product Market Size and Forecast, By Application
14.4 Middle East Embolotherapy Product Market Size and Forecast, By Procedure
14.5 Middle East Embolotherapy Product Market Size and Forecast, By End User
14.6 Middle East Embolotherapy Product Market Size and Forecast, By Country
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16Company Profiles
16.1 Medtronic
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Johnson & Johnson
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Stryker Corporation
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Terumo Medical Systems
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Boston Medical Corporation
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Kaneka Corporation
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Cook Medical
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 BTG PLC
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Abbott Laboratories
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Acandis GmbH
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
16.11.6 Key Strategies
